A new trading day began on Friday, with Codexis Inc (NASDAQ: CDXS) stock price up 5.12% from the previous day of trading, before settling in for the closing price of $4.10. CDXS’s price has ranged from $2.56 to $6.08 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 8.87%. Meanwhile, its annual earnings per share averaged 29.13%. With a float of $79.13 million, this company’s outstanding shares have now reached $81.38 million.
Let’s determine the extent of company efficiency that accounts for 174 employees. In terms of profitability, gross margin is 70.2%, operating margin of -78.72%, and the pretax margin is -96.25%.
Codexis Inc (CDXS) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Codexis Inc is 3.24%, while institutional ownership is 79.24%. The most recent insider transaction that took place on Feb 10 ’25, was worth 94,149. In this transaction 10% Owner of this company bought 22,500 shares at a rate of $4.18, taking the stock ownership to the 8,677,500 shares. Before that another transaction happened on Feb 12 ’25, when Company’s 10% Owner bought 15,000 for $4.00, making the entire transaction worth $59,932. This insider now owns 8,705,000 shares in total.
Codexis Inc (CDXS) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 29.13% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 27.32% during the next five years compared to -39.95% drop over the previous five years of trading.
Codexis Inc (NASDAQ: CDXS) Trading Performance Indicators
Here are Codexis Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.15. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.88, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach -0.69 in one year’s time.
Technical Analysis of Codexis Inc (CDXS)
Looking closely at Codexis Inc (NASDAQ: CDXS), its last 5-days average volume was 0.46 million, which is a drop from its year-to-date volume of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 38.27%. Additionally, its Average True Range was 0.26.
During the past 100 days, Codexis Inc’s (CDXS) raw stochastic average was set at 45.54%, which indicates a significant increase from 42.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.14% in the past 14 days, which was lower than the 66.26% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.83, while its 200-day Moving Average is $3.70. However, in the short run, Codexis Inc’s stock first resistance to watch stands at $4.43. Second resistance stands at $4.54. The third major resistance level sits at $4.73. If the price goes on to break the first support level at $4.13, it is likely to go to the next support level at $3.94. Should the price break the second support level, the third support level stands at $3.83.
Codexis Inc (NASDAQ: CDXS) Key Stats
With a market capitalization of 350.75 million, the company has a total of 81,378K Shares Outstanding. Currently, annual sales are 70,140 K while annual income is -76,240 K. The company’s previous quarter sales were 12,830 K while its latest quarter income was -20,640 K.
